WallStreetZenWallStreetZen

NASDAQ: AVAH
Aveanna Healthcare Holdings Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AVAH

Based on 8 analysts offering 12 month price targets for Aveanna Healthcare Holdings Inc

Min Forecast
$11.00-4.35%
Avg Forecast
$14.25+23.91%
Max Forecast
$16.00+39.13%

Should I buy or sell AVAH stock?

Based on 8 analysts offering ratings for Aveanna Healthcare Holdings Inc.

Buy
Strong Buy
3 analysts 37.5%
Buy
2 analysts 25%
Hold
3 analysts 37.5%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Strong Buy" agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their AVAH stock forecasts and price targets.

AVAH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-09-14
lockedlocked$00.00+00.00%2026-08-28
lockedlocked$00.00+00.00%2026-08-24
lockedlocked$00.00+00.00%2026-08-24
lockedlocked$00.00+00.00%2026-08-14
Raymond James
Top 12%
89
Strong BuyMaintains$15.00+30.43%2026-08-14
BMO Capital
Top 18%
83
BuyMaintains$14.00+21.74%2026-08-14
Stephens & Co.
Top 12%
89
Strong BuyUpgrades$11.00-4.35%2026-05-15Find out why

1 of 1

Forecast return on equity

Is AVAH forecast to generate an efficient return?

Company
66.47%
Industry
-44.33%
Market
145.13%
AVAH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AVAH forecast to generate an efficient return on assets?

Company
10.16%
Industry
9.58%
AVAH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AVAH earnings per share forecast

What is AVAH's earnings per share in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$0.84-42.81%
Avg 2 year Forecast
$0.93-37.07%
Avg 3 year Forecast
$1.03-30.15%
AVAH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AVAH revenue forecast

What is AVAH's revenue in the next 3 years based on estimates from 13 analysts?

Avg 1 year Forecast
$2.7B+2.64%
Avg 2 year Forecast
$3.0B+10.45%
Avg 3 year Forecast
$3.1B+16.98%
AVAH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AVAH earnings growth forecast

How is AVAH forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
-20.44%
Industry
3.59%
Market
70.2%
AVAH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AVAH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AVAH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AVAH revenue growth forecast

How is AVAH forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
4.91%
Industry
3.32%
Market
12.74%
AVAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AVAH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AVAH vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
AVAH$11.50$14.25+23.91%Buy
ARDT$17.80$15.00-15.73%Buy
MD$31.30$28.75-8.15%Hold
ADUS$123.00$136.43+10.92%Buy
BKD$9.17$16.00+74.48%Strong Buy
View Top Medical Care Facility Stocks

Aveanna Healthcare Holdings Stock Forecast FAQ

Is Aveanna Healthcare Holdings Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 8 Wall Street analysts covering (NASDAQ: AVAH) stock is to Buy AVAH stock.

Out of 8 analysts, 3 (37.5%) are recommending AVAH as a Strong Buy, 2 (25%) are recommending AVAH as a Buy, 3 (37.5%) are recommending AVAH as a Hold, 0 (0%) are recommending AVAH as a Sell, and 0 (0%) are recommending AVAH as a Strong Sell.

If you're new to stock investing, here's how to buy Aveanna Healthcare Holdings stock.

What is AVAH's earnings growth forecast for 2026-2028?

(NASDAQ: AVAH) Aveanna Healthcare Holdings's forecast annual earnings growth rate of -20.44% is not forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 3.59%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 70.2%.

Aveanna Healthcare Holdings's earnings in 2026 is $306,149,000.On average, 13 Wall Street analysts forecast AVAH's earnings for 2026 to be $183,616,950, with the lowest AVAH earnings forecast at $168,240,914, and the highest AVAH earnings forecast at $197,223,868. On average, 13 Wall Street analysts forecast AVAH's earnings for 2027 to be $202,028,879, with the lowest AVAH earnings forecast at $175,513,954, and the highest AVAH earnings forecast at $220,156,876.

In 2028, AVAH is forecast to generate $224,262,976 in earnings, with the lowest earnings forecast at $188,356,438 and the highest earnings forecast at $245,383,184.

What is AVAH's revenue growth forecast for 2026-2028?

(NASDAQ: AVAH) Aveanna Healthcare Holdings's forecast annual revenue growth rate of 4.91% is forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 3.32%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 12.74%.

Aveanna Healthcare Holdings's revenue in 2026 is $2,676,418,000.On average, 13 Wall Street analysts forecast AVAH's revenue for 2026 to be $599,971,168,453, with the lowest AVAH revenue forecast at $575,290,883,766, and the highest AVAH revenue forecast at $620,064,851,561. On average, 13 Wall Street analysts forecast AVAH's revenue for 2027 to be $645,618,774,644, with the lowest AVAH revenue forecast at $613,730,973,190, and the highest AVAH revenue forecast at $673,356,793,717.

In 2028, AVAH is forecast to generate $683,840,454,469 in revenue, with the lowest revenue forecast at $647,584,461,035 and the highest revenue forecast at $714,854,617,527.

What is AVAH's forecast return on assets (ROA) for 2026-2028?

(NASDAQ: AVAH) forecast ROA is 10.16%, which is higher than the forecast US Medical Care Facilities industry average of 9.58%.

What is AVAH's Price Target?

According to 8 Wall Street analysts that have issued a 1 year AVAH price target, the average AVAH price target is $14.25, with the highest AVAH stock price forecast at $16.00 and the lowest AVAH stock price forecast at $11.00.

On average, Wall Street analysts predict that Aveanna Healthcare Holdings's share price could reach $14.25 by Sep 14, 2027. The average Aveanna Healthcare Holdings stock price prediction forecasts a potential upside of 23.91% from the current AVAH share price of $11.50.

What is AVAH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AVAH) Aveanna Healthcare Holdings's current Earnings Per Share (EPS) is $1.47. On average, analysts forecast that AVAH's EPS will be $0.84 for 2026, with the lowest EPS forecast at $0.77, and the highest EPS forecast at $0.90. On average, analysts forecast that AVAH's EPS will be $0.93 for 2027, with the lowest EPS forecast at $0.80, and the highest EPS forecast at $1.01. In 2028, AVAH's EPS is forecast to hit $1.03 (min: $0.86, max: $1.12).

What is AVAH's forecast return on equity (ROE) for 2026-2028?

(NASDAQ: AVAH) forecast ROE is 66.47%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.